Published in Am J Ophthalmol on October 01, 1998
Variable R1 region in varicella zoster virus in fulminant type of acute retinal necrosis syndrome. Br J Ophthalmol (2000) 0.81
Nodular Scleritis Associated with Herpes Zoster Virus: An Infectious and Immune-Mediated Process. Case Rep Ophthalmol Med (2016) 0.75
Favorable Long-term Prognosis of Cataract Surgery in Herpes Zoster Ophthalmicus. J Ophthalmic Vis Res (2016) 0.75
Scleritis-associated uveitis. Ophthalmology (1997) 7.34
Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology (1992) 6.62
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol (1996) 5.05
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene (2007) 4.81
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol (2000) 4.70
Nucleotide sequence and predicted amino acid sequence of a protein encoded in a small herpes simplex virus DNA fragment capable of trans-inducing alpha genes. Proc Natl Acad Sci U S A (1985) 3.75
Anatomy of the herpes simplex virus 1 strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal antibody-resistant mutants. J Virol (1985) 3.67
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene (2006) 3.09
Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol (1996) 3.04
Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer (2006) 2.76
Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene (2007) 2.68
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer (2010) 2.45
Mutations affecting conformation or sequence of neutralizing epitopes identified by reactivity of viable plaques segregate from syn and ts domains of HSV-1(F) gB gene. Virology (1984) 2.44
Severity of scleritis and episcleritis. Ophthalmology (1994) 2.43
Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol (1999) 2.42
Anterior chamber crystals following hyphema. Arch Ophthalmol (1990) 2.39
Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma. Ophthalmology (1999) 2.33
Primary human herpesvirus 6 infection in young children. N Engl J Med (1992) 2.30
Infectious endophthalmitis. Review of 36 cases. Ophthalmology (1982) 2.26
Epstein-Barr virus genome may encode a protein showing significant amino acid and predicted secondary structure homology with glycoprotein B of herpes simplex virus 1. J Virol (1985) 2.25
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer (2012) 2.15
Cicatricial pemphigoid. Trans Am Ophthalmol Soc (1986) 2.10
Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res (2000) 1.99
Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Ophthalmology (1995) 1.98
Human herpesvirus 6. Clin Microbiol Rev (1997) 1.91
Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol (2002) 1.91
Mitomycin eye drops as treatment for pterygium. Ophthalmology (1988) 1.89
Immunomodulatory therapy for chronic tubulointerstitial nephritis-associated uveitis. Am J Ophthalmol (2000) 1.84
The characteristic features of optical coherence tomography in posterior uveitis. Br J Ophthalmol (2007) 1.78
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study. Br J Cancer (2009) 1.77
Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. Am J Ophthalmol (1997) 1.71
Monoclonal antibodies to the human mammary gland. I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues. Virchows Arch A Pathol Anat Histol (1982) 1.68
Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea (1991) 1.65
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. Br J Cancer (2008) 1.62
Schirmer test after topical anesthesia and the tear meniscus height in normal eyes. Arch Ophthalmol (1979) 1.62
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60
Posterior capsule opacification after cataract surgery in patients with uveitis. Ophthalmology (1997) 1.59
Characterization and nucleotide sequence of two herpes simplex virus 1 genes whose products modulate alpha-trans-inducing factor-dependent activation of alpha genes. J Virol (1987) 1.57
Transactivation of human immunodeficiency virus by herpesviruses. Oncogene (1987) 1.57
Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology (1999) 1.57
An analysis of therapeutic decision for scleritis. Ophthalmology (1993) 1.55
Wegener's granulomatosis: the relationship between ocular and systemic disease. J Rheumatol (2001) 1.55
The value of combined serum angiotensin-converting enzyme and gallium scan in diagnosing ocular sarcoidosis. Ophthalmology (1995) 1.54
Ocular features associated with anticardiolipin antibodies: a descriptive study. Am J Ophthalmol (2001) 1.53
Ocular syphilis. Ophthalmology (1990) 1.53
Ocular Whipple's disease: earlier definitive diagnosis. Ophthalmology (2001) 1.50
Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid. Ophthalmology (1995) 1.48
Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology (1984) 1.46
An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea (1990) 1.46
Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins. Blood (2001) 1.45
Corneal laser photocoagulation for treatment of neovascularization. Efficacy of 577 nm yellow dye laser. Ophthalmology (1992) 1.44
Ocular rosacea: patient characteristics and follow-up. Ophthalmology (1997) 1.43
Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol (2000) 1.41
Long-term follow-up study of mitomycin eye drops as adjunctive treatment of pterygia and its comparison with conjunctival autograft transplantation. Cornea (1990) 1.40
Molecular basis of disease processes. Hum Pathol (2001) 1.39
Fibronectin in healing rabbit corneal wounds. Lab Invest (1981) 1.37
Immunosuppressive therapy for external ocular inflammatory disease. Ophthalmology (1980) 1.35
Comparison of mechanical properties of keratoconus and normal corneas. Exp Eye Res (1982) 1.34
Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology (1999) 1.34
Factors influencing predilection and outcome in bacterial keratitis. Cornea (1989) 1.33
Individuals from North America, Australasia, and Africa are infected with four different genotypes of human herpesvirus 8. Virology (1999) 1.32
Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol (2001) 1.30
The brown bowel syndrome: a possible smooth muscle mitochondrial myopathy? Histopathology (1979) 1.30
Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology (1997) 1.30
Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients. Prostate Cancer Prostatic Dis (2007) 1.29
Differential expression of voltage-activated Na+ currents in two prostatic tumour cell lines: contribution to invasiveness in vitro. FEBS Lett (1995) 1.27
Immunopathology of scleritis. Ophthalmology (1991) 1.27
Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol (1998) 1.25
Intermediate uveitis and retinal vasculitis as manifestations of cat scratch disease. Am J Ophthalmol (1996) 1.25
Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management. Cornea (1995) 1.25
Changing patterns in uveitis of childhood. Ophthalmology (1996) 1.24
Concepts of epigenetics in prostate cancer development. Br J Cancer (2008) 1.24
Monoclonal antibodies and human tumor pathology. Hum Pathol (1982) 1.24
Glycoprotein B of human herpesvirus 8 is a component of the virion in a cleaved form composed of amino- and carboxyl-terminal fragments. Virology (2000) 1.24
Squamous cell carcinoma of the conjunctiva. Int Ophthalmol Clin (1997) 1.24
Miconazole therapy for keratomycosis. Am J Ophthalmol (1981) 1.24
Identification of a lytic-phase origin of DNA replication in human herpesvirus 6B strain Z29. J Virol (1993) 1.23
Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection. J Clin Microbiol (1990) 1.23
Growth properties of human herpesvirus-6 strain Z29. J Virol Methods (1989) 1.23
bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol (1996) 1.23
A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis (2005) 1.22
Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol (1999) 1.22
Sarcoidosis and its ocular manifestations. Int Ophthalmol Clin (1996) 1.22
Scleritis associated with systemic vasculitic diseases. Ophthalmology (1995) 1.22
Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology (2001) 1.21
Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. Am J Pathol (1999) 1.20
Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology (1982) 1.19
Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells. FEBS Lett (1998) 1.18
Properties of the human herpesvirus 6 strain Z29 genome: G + C content, length, and presence of variable-length directly repeated terminal sequence elements. Virology (1991) 1.18
Basement membrane components in healing rabbit corneal epithelial wounds: immunofluorescence and ultrastructural studies. J Cell Biol (1984) 1.17
Gas-permeable scleral contact lens therapy in ocular surface disease. Am J Ophthalmol (2000) 1.17
Six cases of scleritis associated with systemic infection. Am J Ophthalmol (1992) 1.16
Frequent isolation of human herpesvirus 7 from saliva. Virus Res (1993) 1.16
Amniotic membrane surgery. Curr Opin Ophthalmol (2001) 1.15